|

Yield of Implantable Cardiac Monitoring Device in Patients With Acute Ischemic Stroke.

RECRUITINGN/ASponsored by National and Kapodistrian University of Athens
Actively Recruiting
PhaseN/A
SponsorNational and Kapodistrian University of Athens
Started2023-05-05
Est. completion2027-01-01
Eligibility
Age40 Years – 100 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05494034

Summary

In this prospective cohort study, the investigators aim to investigate the incidence of ICM-detected AF in unselected ischemic stroke patients and its association with anticoagulation initiation and stroke recurrence.

Eligibility

Age: 40 Years – 100 YearsHealthy volunteers accepted
Inclusion Criteria:

* Consecutive acute ischemic stroke or TIA patients aged 40 years or older will be enrolled.
* Diagnosis of acute ischemic stroke will be based on clinical and neuroimaging evaluation \[brain computed tomography (CT) scan or magnetic resonance imaging (MRI) scan\].
* Stroke patients of all other etiologies (apart AF) presenting a HAVOC score ≥4 will be included in the study.
* Informed consent for participation in the study will be obtained from the patients or guardians of patients.

Exclusion Criteria:

* Patients with incomplete evaluation will be excluded, as previously described. \[22\] -Patients with known or newly detected AF at hospitalization will also be excluded.
* Not providing informed consent.

Conditions5

Atrial FibrillationHeart DiseaseStrokeStroke, AcuteStroke, Ischemic

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.